Google Chrome
Safari
Firefox
Edge
Search
News / Sep 09, 2024
Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions
Hovione commitment to setting SBTs in line with the Paris Agreement
Press Clipping / Jun 21, 2021
Hovione meets increased demand during Covid
Irish Examiner, 21 june 2021
Press Release / May 07, 2026
Hovione and IDC Intranasal Drug Delivery Platform Available for Commercial Partnerships
Its lead single-use nasal dry powder device now available for commercial partnerships
Press Release / Aug 23, 2022
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.
Press Release / Mar 17, 2021
Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Press Release / Jun 18, 2024
Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Article / Feb 23, 2026
Hovione’s Diane Villax: “I was not brought up to be a business woman”
Executiva, 23 February 2026
Press Release / Feb 25, 2022
Jean-Luc Herbeaux to become Hovione CEO
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022